A slow-release dexamethasone implant for cancer-associated retinopathy

ABSTRACT This case report aims to show the anatomical and functional results of a patient diagnosed as having cancer-associated retinopathy treated with a controlled-release dexamethasone implant (Ozurdex). Anatomical outcomes were assessed using spectral domain optical coherence tomography; and functional outcomes, by measuring visual acuity, microperimetry, and mutifocal electroretinography. The follow-up period was 1 year.

摘要 本病例报告旨在展示1例确诊罹患癌症相关性视网膜病变的患者接受控释地塞米松植入剂（Ozurdex）治疗后的解剖学与功能学结局。解剖学结局采用光谱域光学相干断层扫描进行评估；功能学结局则通过视力检测、微视野检查以及多焦视网膜电图（mutifocal electroretinography）进行评估。本次随访周期为1年。